Raleigh Capital Management Inc. Bristol Myers Squibb CO Transaction History
Raleigh Capital Management Inc.
- $214 Million
- Q1 2025
A detailed history of Raleigh Capital Management Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Raleigh Capital Management Inc. holds 32,458 shares of BMY stock, worth $1.5 Million. This represents 0.93% of its overall portfolio holdings.
Number of Shares
32,458
Previous 39,439
17.7%
Holding current value
$1.5 Million
Previous $2.23 Million
11.26%
% of portfolio
0.93%
Previous 0.88%
Shares
14 transactions
Others Institutions Holding BMY
# of Institutions
2,811Shares Held
1.59BCall Options Held
25.9MPut Options Held
23.9M-
Vanguard Group Inc Valley Forge, PA191MShares$8.86 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.34 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$5 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.39 Billion0.24% of portfolio
-
Capital International Investors Los Angeles, CA66.5MShares$3.08 Billion0.83% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $98.4B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...